Cleared Traditional

SpotLight/SpotLight Duo with Low Dose Lung Cancer Screening Option (K241200) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K241200 · Arineta , Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2025
Decision
258d
Days
Class 2
Risk

K241200 is an FDA 510(k) clearance for the SpotLight/SpotLight Duo with Low Dose Lung Cancer Screening Option. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Arineta , Ltd. (Caesarea, IL). The FDA issued a Cleared decision on January 13, 2025 after a review of 258 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Arineta , Ltd. devices

Submission Details

510(k) Number K241200 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 30, 2024
Decision Date January 13, 2025
Days to Decision 258 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
151d slower than avg
Panel avg: 107d · This submission: 258d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 421
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K241200.
NAEOTOM Alpha.Peak/ NAEOTOM Alpha
K243523 · Siemens Medical Solutions USA, Inc. · Feb 2025
Bunkerhill AVC
K243229 · BunkerHill Health · Jan 2025
uCT 550
K241166 · Shanghai United Imaging Healthcare Co., Ltd. · Jan 2025
uCT 780
K241079 · Shanghai United Imaging Healthcare Co., Ltd. · Jan 2025
syngo.CT Dual Energy
K241757 · Siemens Medical Solutions USA, Inc. · Jan 2025
Aquilion ONE (TSX-308A/3) V1.5
K242403 · Canon Medical Systems Corporation · Dec 2024